CTD Holdings Closes $2 Million Private Placement

ALACHUA, FL CTDH, (Marketwired February 23, 2017) CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease, today announced that it has closed a private placement of its securities with a group of accredited investors that included several directors of the Company and members of management. Investors in the private placement purchased 5,754,832 units at a price per unit of $0.35. Each unit consisted of one share of common
http://bit.ly/2kQMEJN